{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:39:05Z","timestamp":1791362345156,"version":"4.3.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.tvjl.2024.106196","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T07:36:48Z","timestamp":1720942608000},"page":"106196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prospective study of successful autologous dendritic cell therapy in dogs with splenic stage II hemangiosarcoma"],"prefix":"10.1016","volume":"306","author":[{"given":"V.","family":"Spiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dettmer-Richardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Grammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2024.106196_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/vco.12891","article-title":"Chronic adrenergic stress and generation of myeloid-derived suppressor cells: Implications for cancer immunotherapy in dogs","volume":"21","author":"Ammons","year":"2023","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/eve.12741","article-title":"Immunotherapy of a squamous cell carcinoma in the perianal region using autologous dendritic cells in a horse","volume":"30","author":"Arnold","year":"2018","journal-title":"Equine Vet. Educ."},{"key":"10.1016\/j.tvjl.2024.106196_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1586\/14760584.2014.957684","article-title":"mRNA-based dendritic cell vaccines","volume":"14","author":"Benteyn","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tvjl.2024.106196_bib4","unstructured":"Bischoff, S., 2009. Therapie equiner Sarkoide unter Verwendung dendritischer Zellen. Freie Universit\u00e4t Berlin, Berlin. https:\/\/refubium.fu-berlin.de\/handle\/fub188\/4869?show=full."},{"key":"10.1016\/j.tvjl.2024.106196_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/nri.2016.115","article-title":"Sorting, sorted!","volume":"16","author":"Bordon","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/1535-7163.MCT-16-0637","article-title":"Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR","volume":"16","author":"Borgatti","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tvjl.2024.106196_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jsap.12796","article-title":"Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?","volume":"59","author":"Bray","year":"2018","journal-title":"J. Small Anim. Pract."},{"key":"10.1016\/j.tvjl.2024.106196_bib8","article-title":"In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?","volume":"10","author":"Castiello","year":"2019","journal-title":"Front.\u00a0Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib9","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2012-01-408260","article-title":"How many dendritic cells are required to initiate a T-cell response?","volume":"120","author":"Celli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tvjl.2024.106196_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/vco.12782","article-title":"Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs","volume":"20","author":"Chavalle","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1939-1676.2000.tb02262.x","article-title":"Treatment of canine hemangiosarcoma: 2000 and beyond","volume":"14","author":"Clifford","year":"2000","journal-title":"J. Vet. Intern Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5326\/JAAHA-MS-5525","article-title":"Treatment with DAV for Advanced-Stage Hemangiosarcoma in Dogs","volume":"47","author":"Dervisis","year":"2011","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.tvjl.2024.106196_bib13","article-title":"Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion","volume":"10","author":"DeVito","year":"2019","journal-title":"Front.\u00a0Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018801","article-title":"Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis","volume":"6","author":"Draube","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tvjl.2024.106196_bib15","first-page":"250","article-title":"Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011)","volume":"40","author":"Eberle","year":"2012","journal-title":"Tierarztlich- Praxis Ausgabe K Kleintiere Heimtiere"},{"key":"10.1016\/j.tvjl.2024.106196_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/vco.12925","article-title":"Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma","volume":"21","author":"Estabrooks","year":"2023","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib17","unstructured":"European Pharmacopoeia, 11.0. ed, 2023."},{"key":"10.1016\/j.tvjl.2024.106196_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/vco.12193","article-title":"A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma","volume":"15","author":"Finotello","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/vco.12139","article-title":"Comparison of doxorubicin-cyclophosphamide with doxorubicin-dacarbazine for the adjuvant treatment of canine hemangiosarcoma","volume":"15","author":"Finotello","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12917-015-0446-1","article-title":"Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma","volume":"11","author":"Gardner","year":"2015","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.tvjl.2024.106196_bib21","unstructured":"Grammel, T., 2016. A pilot uncontrolled study of postsurgical treatment with autologous dendritic cell-based immunologic therapy in 10 dogs with splenic hemangiosarcoma, in: 3rd World Veterinary Cancer Congress, Foz Do Iguassu\/Brazil May 25-29, 2016."},{"key":"10.1016\/j.tvjl.2024.106196_bib22","unstructured":"Grammel, T., Hawacker, T., Hettling, H., Grammel, S., 2019. Quality of life of dogs during immunologic treatment with monocyte-derived dendritic cells, in: 25th FECAVA EuroCongress, St. Petersburg, Russia, September 2019."},{"key":"10.1016\/j.tvjl.2024.106196_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/vco.12796","article-title":"The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression","volume":"20","author":"Gulay","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1939-1676.1991.tb00943.x","article-title":"Efficacy and Toxicity of VAC Chemotherapy (Vincristine, Doxorubicin, and Cyclophosphamide) in Dogs with Hemangiosarcoma","volume":"5","author":"Hammer","year":"1991","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13062-022-00318-w","article-title":"Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number","volume":"17","author":"Hawlina","year":"2022","journal-title":"Biol. Direct"},{"key":"10.1016\/j.tvjl.2024.106196_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.omtm.2019.12.017","article-title":"Manufacturing dendritic cells for immunotherapy: monocyte enrichment","volume":"16","author":"Hopewell","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tvjl.2024.106196_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib28","first-page":"237","article-title":"Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study","volume":"54","author":"Kahn","year":"2013","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.tvjl.2024.106196_bib29","doi-asserted-by":"crossref","unstructured":"Kessler, M., 2022. Kleintieronkologie, 4th ed. Georg Thieme Verlag KG, Stuttgart. https:\/\/doi.org\/10.1055\/b-006-163261.","DOI":"10.1055\/b-006-163261"},{"key":"10.1016\/j.tvjl.2024.106196_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/vetsci2040388","article-title":"Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives","volume":"2","author":"Kim","year":"2015","journal-title":"Vet. Sci."},{"key":"10.1016\/j.tvjl.2024.106196_bib31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2460\/javma.231.10.1550","article-title":"Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997\u20132004)","volume":"231","author":"Kim","year":"2007","journal-title":"J. Am. Vet. Med.\u00a0Assoc."},{"key":"10.1016\/j.tvjl.2024.106196_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41417-019-0080-3","article-title":"Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma","volume":"26","author":"Konduri","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tvjl.2024.106196_bib33","unstructured":"Korpela, D., Saha, J., Khammanivong, A., Brown, D., Dickerson, E., 2021. Veterinary Cancer Society, Annual Conference 2021: PROPRANOLOL REDUCES HEMANGIOSARCOMA CELL VIABILITYBY DISRUPTING LIPID HOMEOSTASIS AND INDUCING ER STRESS, in: Abstracts from the 2021 Veterinary Cancer Society (VCS) Annual Conference, 4-6 November 2021."},{"key":"10.1016\/j.tvjl.2024.106196_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/669665","article-title":"The size\u2013life span trade-off decomposed: why large dogs die young","volume":"181","author":"Kraus","year":"2013","journal-title":"Am. Nat."},{"key":"10.1016\/j.tvjl.2024.106196_bib35","first-page":"764","article-title":"Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs","volume":"21","author":"Lana","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/eji.1830201103","article-title":"Interleukin 4 down-regulates the expression of CD14 in normal human monocytes","volume":"20","author":"Lauener","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib37","article-title":"Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders","volume":"13","author":"Lazarus","year":"2023","journal-title":"Front.\u00a0Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00262-012-1207-7","article-title":"Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma","volume":"61","author":"Leonhartsberger","year":"2012","journal-title":"Cancer Immunol.\u00a0Immunother."},{"key":"10.1016\/j.tvjl.2024.106196_bib39","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1158\/0008-5472.CAN-10-0600","article-title":"IFN\u03b3 markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models","volume":"70","author":"Mito","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.tvjl.2024.106196_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2460\/javma.251.5.559","article-title":"Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011\u20132014)","volume":"251","author":"Moore","year":"2017","journal-title":"J. Am. Vet. Med.\u00a0Assoc."},{"key":"10.1016\/j.tvjl.2024.106196_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1939-1676.1996.tb02085.x","article-title":"Surgery and doxorubicin in dogs with hemangiosarcoma","volume":"10","author":"Ogilvie","year":"1996","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib42","first-page":"456","article-title":"Chirurgische Resektion und adjuvante dendritische Zelltherapie eines nasopharyngealen Mastzelltumors bei einem Sch\u00e4ferhund","volume":"66","author":"Pantke","year":"2021","journal-title":"Kleintier-Praxis"},{"key":"10.1016\/j.tvjl.2024.106196_bib43","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V77.9.1859.1859","article-title":"Interleukin-4: a prototypic immunoregulatory lymphokine","volume":"77","author":"Paul","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.tvjl.2024.106196_bib44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bimj.200410133","article-title":"The Youden Index and the Optimal Cut-Point Corrected for Measurement Error","volume":"47","author":"Perkins","year":"2005","journal-title":"Biom. J."},{"key":"10.1016\/j.tvjl.2024.106196_bib45","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1939-1676.2012.00966.x","article-title":"Prospective study of thrombospondin-1 mimetic peptides, ABT-510 and ABT-898, in dogs with soft tissue sarcoma","volume":"26","author":"Sahora","year":"2012","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.1701024","article-title":"Dendritic Cell\u2013Based Cancer Vaccines","volume":"200","author":"Santos","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib47","unstructured":"Scholz, C., 2005. Dendritische Zellen in der Immuntherapie des Pankreaskarzinoms: Einfluss der Antigenaufbereitung aus vitalen Tumorzellen auf die Immunantwort in vitro. Ludwig-Maximilians-Universit\u00e4t Munich. https:\/\/edoc.ub.uni-muenchen.de\/4536\/1\/Scholz_Christoph.pdf."},{"key":"10.1016\/j.tvjl.2024.106196_bib48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/104063870401600606","article-title":"A Retrospective Study of Visceral and Nonvisceral Hemangiosarcoma and Hemangiomas in Domestic Animals","volume":"16","author":"Schultheiss","year":"2004","journal-title":"J. Vet. Diagn. Investig."},{"key":"10.1016\/j.tvjl.2024.106196_bib49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1939-1676.2000.tb02247.x","article-title":"Canine hemangiosarcoma treated with standard chemotherapy and minocycline","volume":"14","author":"Sorenmo","year":"2000","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/vsu.13470","article-title":"Outcomes of 43 small breed dogs treated for splenic hemangiosarcoma","volume":"49","author":"Story","year":"2020","journal-title":"Vet. Surg."},{"key":"10.1016\/j.tvjl.2024.106196_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1476-5829.2011.00282.x","article-title":"Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*","volume":"10","author":"Szivek","year":"2012","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib52","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.140.5.1548","article-title":"Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4","volume":"140","author":"te Velde","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1476-5829.2011.00266.x","article-title":"A randomized controlled study into the efficacy and toxicity of pegylated liposome encapsulated doxorubicin as an adjuvant therapy in dogs with splenic haemangiosarcoma","volume":"9","author":"Teske","year":"2011","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/vco.12809","article-title":"Risk factors associated with the onset of lomustine-induced neutropenia in tumour-bearing dogs","volume":"20","author":"Treggiari","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2024.106196_bib55","article-title":"Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma","volume":"21","author":"U\u2019Ren","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","article-title":"Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage","volume":"100","author":"Ushach","year":"2016","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.tvjl.2024.106196_bib57","first-page":"1165","article-title":"Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial","volume":"1","author":"Vail","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tvjl.2024.106196_bib58","series-title":"in: Withrow and MacEwen\u2019s Small Animal Clinical Oncology","first-page":"773","article-title":"Miscellaneous Tumors","author":"Vail","year":"2020"},{"key":"10.1016\/j.tvjl.2024.106196_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1939-1676.1994.tb03248.x","article-title":"Cutaneous hemangiosarcoma in 25 dogs: a retrospective study","volume":"8","author":"Ward","year":"1994","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tvjl.2024.106196_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2460\/javma.247.4.393","article-title":"Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001\u20132012)","volume":"247","author":"Wendelburg","year":"2015","journal-title":"J. Am. Vet. Med.\u00a0Assoc."},{"key":"10.1016\/j.tvjl.2024.106196_bib62","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1084\/jem.166.5.1484","article-title":"Granulocyte\/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells","volume":"166","author":"Witmer-Pack","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tvjl.2024.106196_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264986","article-title":"Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients","volume":"17","author":"Wong","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.tvjl.2024.106196_bib64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5326\/15473317-34-5-417","article-title":"Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993)","volume":"34","author":"Wood","year":"1998","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.tvjl.2024.106196_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","article-title":"Exosomes as a new frontier of cancer liquid biopsy","volume":"21","author":"Yu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tvjl.2024.106196_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp. Hematol. Oncol."}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023324001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023324001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T02:43:46Z","timestamp":1732416226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023324001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":66,"alternative-id":["S1090023324001357"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2024.106196","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective study of successful autologous dendritic cell therapy in dogs with splenic stage II hemangiosarcoma","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2024.106196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106196"}}